Ali Hassan
2 min read
In This Article:
On May 19, The Chemours Company (NYSE:CC) announced its partnership with DataVolt, an operator of data management platforms with supercomputing capabilities, to develop advanced liquid cooling solutions for AI data centres.
Chemours’ two-phase direct-to-chip and immersion cooling technology has gained momentum, driven by growing demand for data centres.
A modern computer datacenter, running an advanced quantum computer system.
To enhance sustainability for AI and next-generation chips, Chemours and Datavolt will develop a system that will reduce cooling energy by almost 90%, lowering the total cost of ownership by 40%. With Chemours' technology, there will be no need for water use to enhance cooling efficiency for AI data centres. The growing demand for AI data centres strengthens Chemours' position in sustainable thermal management.
The Chemours Company (NYSE:CC) also has an agreement with Navin Fluorine to produce Opteon two-phase immersion cooling fluid, fulfilling data centre cooling needs. Goldman Sachs Research projects global power demand from data centres to increase 50% by 2027 and nearly 165% by the end of 2030, driven by AI. This growing demand will create opportunities for players like Chemours and DataVolt to minimize operational costs for data centres.
The Chemours Company (NYSE:CC) offers industrial and speciality products for various industries, including coating, plastics, semiconductor, transportation, oil and gas, and refrigeration and air conditioning, among others. The company serves over 2,700 customers through its top-rated brands such as Opteon, Freon, Viton, Krytox, Ti-Pure, Nafion, and Teflon.
While we acknowledge the potential of CC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CC and that has 100x upside potential, check out our report about this cheapest AI stock.
Read Next: 30 Best Stocks to Buy Now According to Billionaires and 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying.
Disclosure. None.
